
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. (SPRO)
Price
Market cap
Next catalystQ2 2027, subject to FDA clearance of the U.S. INDSP001 — planned IgG4-RD Phase 2 study · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
PreINDP1P3FilingApproved
Other pipelines
Approved / commercial
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved